Andrew Burch - Dec 31, 2023 Form 5 Insider Report for MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)

Role
President, Nucleic Acid Production
Signature
/s/ Kurt Oreshack, by power of attorney for Andrew Burch
Stock symbol
MRVI
Transactions as of
Dec 31, 2023
Transactions value $
$0
Form type
5
Date filed
1/18/2024, 06:15 PM
Previous filing
Apr 6, 2023
Next filing
Jan 18, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRVI Class A Common Stock Award +141K 141K Apr 17, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRVI Employee Stock Options (Right to Buy) Award $0 +80K $0.00 80K Apr 17, 2023 Class A Common Stock 80K $14.14 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs") awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan. Each RSU represents the right to receive one share of Class A Common Stock of the Issuer upon vesting. The RSUs will vest in 1/3rd increments on each of April 15, 2024, April 15, 2025, and April 15, 2026, subject to the Reporting Person's continued employment with the Issuer.
F2 Represents options awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan. These options will vest 25% on April 15, 2024 and in equal 1/48th installments each month thereafter, subject to the Reporting Person's continued employment with the Issuer.

Remarks:

President, Nucleic Acid Production